Pristiq Low Dose Shows Benefit In Treating MDD
Data on Wyeth’s investigational SNRI was submitted to FDA in August, with action expected in the first quarter.
Data on Wyeth’s investigational SNRI was submitted to FDA in August, with action expected in the first quarter.